Solubility enhancement of diacerein through liquisolid technology: a formulation perspective

Monika Nijhawan; Rajeswari Aleti; Sravani Maramwar; Dedipya Goda Srivalli Vangala; Trapti Saxena

doi:10.56782/pps.477

Published : 2025-10-01

Vol. 24 No. 1 (2026)

Solubility enhancement of diacerein through liquisolid technology: a formulation perspective

Monika Nijhawan

Rajeswari Aleti

Sravani Maramwar

Dedipya Goda Srivalli Vangala

Trapti Saxena

DOI: https://doi.org/10.56782/pps.477

Abstract

Liquisolid systems present an effective technique for improving the dissolution rate and oral bioavailability of poorly water-soluble drugs. The objective of this study is to formulate and evaluate diacerein liquisolid compacts using Tween 80 as the liquid vehicle, Neusilin and Fujicalin as carriers, and Aerosil 200 as a coating material. Sodium starch glycolate and magnesium stearate were used as disintegrants and lubricants, respectively. Pre- and post-compression parameters such as flow properties, hardness, friability, drug content, and disintegration time were measured. The in vitro release characteristics of the pure drug, marketed capsules (as reference), and liquisolid technique (test sample) were studied. Among all the formulations, FSC3 had the highest dissolving efficiency (DE) of 53.109% at 60 minutes, exceeding the marketed product's DE of 44.972%. FTIR analysis revealed no drug-excipient incompatibility, and all tested formulations fulfilled pharmacopeial requirements for flow and mechanical characteristics. Overall, the study demonstrates that the liquisolid technique significantly improves the dissolution of diacerein, indicating its potential to boost the physicochemical properties of poorly soluble drugs.

Keywords:

liquisolid compacts, Diacerein, Solubility enhancement, poorly aqueous soluble, formulation development

Similar Articles

Rama Devi Korni, Thanmaisree Bora, Akhil Majji, Jagadeesh Panda, Liquisolid technique for solubility enhancement of a poorly soluble thrombin inhibitor: optimization using design of experiments and artificial neural networks , Prospects in Pharmaceutical Sciences: Vol. 23 No. 3 (2025)
Dr. Ashwini Madgulkar, Dr. Mangesh Bhalekar, Abhishek Kunjir, Maryam Mulla, A SCIENTIFIC EXPLORATION OF CO-AMORPHOUS FORMULATION DRIVEN BY KNOWLEDGE BASED VIRTUAL SCREENING FOR SOLUBILITY AND BIOAVAILABILITY ENHANCEMENT OF DARUNAVIR , Prospects in Pharmaceutical Sciences: No. 2025 (Early Access)
Vidya Patil, Shivraj Jadhav, Sunil Mahajan, Development and optimization of danazol co-crystal loaded tablet to treat endometriosis , Prospects in Pharmaceutical Sciences: Vol. 23 No. 4 (2025)
Vijayraj Sonawane, Dhanashree I. Wagh, Sakshi P. Bhamare, Khemchand R. Surana, Deepak D. Sonawane, Sunil K. Mahajan, Enhancing water solubility of a BCS Class II drug using hydrotropy, mixed solvency, co-solvency, and nanosuspension techniques , Prospects in Pharmaceutical Sciences: Vol. 23 No. 4 (2025)
Monika Nijhawan, Bhavana Jidige, Rajeswari Aleti, Sailaja Gunnam, Trapti Saxena, Development and characterization of voriconazole-oxalic acid dihydrate cocrystals for enhanced pharmaceutical performance , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Komal Parmar, Rishi Bharatia, Novel flucytosine loaded in-situ gel for the management of ocular infections , Prospects in Pharmaceutical Sciences: Vol. 23 No. 3 (2025)
Paulina Oleksa, Daria Żuraw, Kacper Jasiński, Mateusz Sobczyk, Mikołaj Porzak, Alicja Sodolska, Karolina Haczkur-Pawłowska, Drugs and other chemical substances inducing diabetes – review of the literature , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Rushikesh Mahale, Shivraj Jadhav, Sunil Mahajan, Development and optimization of gastro retentive floating tablets of dapsone for controlled release , Prospects in Pharmaceutical Sciences: Vol. 24 No. 1 (2026)
Mayur S. Bhamare, Ganesh B. Sonawane , Vijayraj N. Sonawane , Chandrashekar D. Patil, Rushikesh L. Bachhav, Sunil K. Mahajan, Dipak D. Sonawane , Strategic development and validation of a stability-indicating analytical method for S-adenosylmethionine , Prospects in Pharmaceutical Sciences: Vol. 23 No. 4 (2025)
Dharani B, Suba A, A novel targeted formulation for osteoarthritis: exploring synergistic benefits of Cissus quadrangularis, Boswellia serrata, propolis and palmitoylethanolamide , Prospects in Pharmaceutical Sciences: Vol. 24 No. 1 (2026)

1 2 3 4 5 6 7 8 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF

Citation rules

Nijhawan, M., Aleti, R., Maramwar, S., Vangala, D. G. S., & Saxena, T. (2025). Solubility enhancement of diacerein through liquisolid technology: a formulation perspective. Prospects in Pharmaceutical Sciences, 24(1), 39–45. https://doi.org/10.56782/pps.477

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

1. Kumari, L.; Choudhari, Y.; Patel, P.; Gupta, GD.; Singh, D.; Rosenholm, J.M.; Bansal, K.K.; Kurmi, B.D. Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs. Life 2023, 13(5), Art. No: 1099. DOI: 10.3390/life13051099

2. Kumar; H.; Rajpoot. A.K.; Sharma, S.; Kumar, A. Solid Lipid Nanoparticles: A Strategy to Improve Oral Delivery of the Biopharmaceutics Classification System (BCS) Class II Drugs. Int. J. Pharm. Biol. Sci. Arch. 2018, 9(4), 204-215.

3. Eltobshi, A.A.; Mohamed, E.A.; Abdelghani, G.M.; Nouh, A.T. Self-nanoemulsifying drug-delivery systems for potentiated anti-inflammatory activity of diacerein. Int. J. Nanomed. 2018, 13, 6585-6602. DOI: 10.2147/IJN.S178819

4. Premakumar, SV.; B. A, Vishwanath.; Deepthi Swapna. Enhancement of Solubility and Dissolution Rate of BCS Class II Drugs. Int. J. Pharm. Sci. Rev. Res. 2024, 84(7), 153-161. DOI: 10.47583/ijpsrr.2024.v84i07.023

5. Talekar, S.; Dave, R. Solubility enhancement of a BCS class II drug using granulated fumed silica as an adsorbent. J. Pharm. Res. Int. 2017, 18(6), Art. No: JPRI.36872. DOI: 10.9734/JPRI/2017/36872

6. Kumar Nagabandi, V.; Ramarao, T.; Jayaveera, K.N. Liquisolid compacts: a novel approach to enhance bioavailability of poorly soluble drugs. Int. J. Pharm. Biol. Sci. 2011, 1(3), 89-102.

7. Dias, RJ.; Mali, KK.; Ghorpade, VS.; Havaldar, VD.; Mohite, VR. Formulation and evaluation of carbamazepine liquisolid compacts using novel carriers. Indian. J. Pharm. Educ. Res. 2017, 51(S2), S69-78. DOI: 10.5530/ijper.51.2s.52

8. Nijhawan, M.; Santhosh, A.; Babu, PR.; Subrahmanyam, CV. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization. Drug. Dev. Ind. Pharm. 2013, 40(9), 1163-1172. DOI: 10.1590/s2175 97902022e191024

9. Suryawanshi, V.K.; Gidwani, B.; Verma, A.; Dubey, N.; Kaur, C.D. Formulation and evaluation of ramipril liquisolid compact using novel carrier. Int. J. Pharm. Sci. Res. 2019, 10(2), 917-25. DOI: 10.13040/IJPSR.0975-8232

10. Wankhede Navneet, B.; Walekar, S. S.; Sadgir, P.S.; Ahirrao, S.P. Liquisolid: A Novel Technique for Dissolution Enhancement of Poorly Water-Soluble Drugs. Asian J. Pharm. Technol. Innov. 2014, 2(8), 77-90.

11. El-Hammadi, M.; Awad, N. Investigating the use of liquisolid compacts technique to minimize the influence of pH variations on loratadine release. AAPS PharmSciTech. 2012, 13(1), 53-58. DOi: 10.1208/s12249-011-9719-6

12. Patel, G.K.; Patel, J. Formulation and evaluation of liquisolid compacts of rivaroxaban. Int. J. Emerg. Technol. Innov. Res. 2022, 9(7), e152-e162

13. Spireas, S.; Bolton, M. Liquisolid systems and methods of preparing same. (Patent No: 6,423,339). United States Patent. 2002. Available at: https://patents.google.com/patent/US6423339B1/en (Accessed on 11 February 2025)

14. Sai, P.D.; Sivaiah, K.V.; Bonthagarala, B.; Rao, P.V. Review on liquisolid compact technology. World. J. Pharm. Res. 2014, 4, 293-306.

15. Nijhawan, M.; Godugu, M.; Saxena, T.; Farheen, T.; Dwivedi, K. Pharmaceutical co-crystals of posaconazole for improvement of physicochemical properties. Braz. J. Pharm. Sci. 2022, 58, Art. No: e191024. DOI: 10.1590/s2175 97902022e191024

16. Andrew E.C et al. Formulation and in Vitro Evaluation of Liquisolid Compact of Celecoxib. Mathews J. Pharm. Sci. 2024, 8(2), Art. No: 31. DOI: 10.30654/MJPS.10031

17. Patel, U.B.; Modi, D.C.; Shah, D.P. Liquisolid compacts: A review. Int. J. Adv. Pharm. 2017, 6(7), 110-3.

18. Madhavi Harika Srimathkandala, Sushma M, Madhu Babu Ananthula, Vasudha Bakshi. Formulation and evaluation of Loperamide Liquisolid compacts. Int. J. Pharm. 2016, 6(2), 93-99.

19., Costa, P.; Sousa Lobo, J.M.. Modeling and comparison of dissolution profiles, Eur. J. Pharm. Sci. 2001, 13(2), 123-133. DOI: 10.1016/s0928-0987(01)00095-1

20. Kassaye, L.; Genete, G. Evaluation and comparison of in-vitro dissolution profiles for different brands of amoxicillin capsules. Afr. Health. Sci. 2013, 13(2), 369-375. DOI: 10.4314/ahs.v13i2.25

Monika Nijhawan

monika8009@grcp.ac.in

Affiliation:

a:1:{s:5:"en_US";s:38:"Gokaraju Rangaraju College of Pharmacy";} India

Solubility enhancement of diacerein through liquisolid technology: a formulation perspective

Monika Nijhawan

Rajeswari Aleti

Sravani Maramwar

Dedipya Goda Srivalli Vangala

Trapti Saxena

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Monika Nijhawan

Rajeswari Aleti

Sravani Maramwar

Dedipya Goda Srivalli Vangala

Trapti Saxena